Nick Pizzie
2019
In 2019, Nick Pizzie earned a total compensation of $1.6M as Chief Financial Officer at Axsome Therapeutics, a 128% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,000 |
|---|---|
| Option Awards | $1,049,837 |
| Salary | $325,000 |
| Total | $1,569,838 |
Pizzie received $1M in option awards, accounting for 67% of the total pay in 2019.
Pizzie also received $195K in non-equity incentive plan and $325K in salary.
Rankings
In 2019, Nick Pizzie's compensation ranked 7,109th out of 13,971 executives tracked by ExecPay. In other words, Pizzie earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,109 out of 13,971 | 49th |
Division Manufacturing | 2,734 out of 5,701 | 52nd |
Major group Chemicals And Allied Products | 1,009 out of 2,200 | 54th |
Industry group Drugs | 855 out of 1,886 | 55th |
Industry Pharmaceutical Preparations | 630 out of 1,398 | 55th |
Pay ratio
| Nick Pizzie's Pay | $1,569,838 |
|---|---|
| Median Employee's Pay | $166,021 |
| Pay Ratio | 9to 1 |
In 2019, the annual total compensation of Nick Pizzie was $1,569,838.
The annual total compensation of the median employee at Axsome Therapeutics was $166,021.
The ratio of Nick Pizzie's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on April 21, 2020.
Pizzie's colleagues
We found three more compensation records of executives who worked with Nick Pizzie at Axsome Therapeutics in 2019.